A new study investigated the effects of metformin on all-cause and exacerbation-related hospitalization rates in patients with coexisting chronic obstructive pulmonary disease and diabetes.
Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, is safe and effective in treatment of severe uncontrolled, eosinophilic asthma, according to two new industry-funded studies.
Two new studies investigated the safety and efficacy of benralizumab in improving symptoms and exacerbation rates of patients with asthma and elevated eosinophil levels.
Millions of individuals in the United States have asthma of different types and severity. Do you think all of those individuals should be classified as having obstructive pulmonary disease? Let us know by...
